Anti-inflammatory compounds

Details for Australian Patent Application No. 2006224796 (hide)

Owner Novartis AG

Inventors Meingassner, Josef Gottfried

Agent Davies Collison Cave

Pub. Number AU-A-2006224796

PCT Pub. Number WO2006/097292

Priority 0505541.3 17.03.05 GB

Filing date 15 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097292 Priority application(s): WO2006/097292

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224797-Combination of a steroid sulfatase inhibitor and an ascomycin

2006224792-Nutritional compositions for modulating Vitamin C bio-availability